Skip to content

MDMA: all studies

Page 159 of 345: studies 1,581 to 1,590 of 3,446, newest first. Back to the MDMA overview

Research

Acute medical problems due to Ecstasy use. Case-series of emergency department visits.

October 29, 2005 Matthias E. Liechti, Isabelle Kunz, Hugo Kupferschmidt 58 citations

STUDY AIM: To describe the clinical characteristics of Ecstasy (3,4-Methylenedioxymethamphetamine, MDMA) toxicity. METHODS: Retrospective case-study of 52 self-reported Ecstasy intoxications presenting to our Emergency Department (ED) between January 2001 and December 2003. RESULTS: Most patients ingested Ecstasy together with other substances, including alcohol (51.9%) or other illicit drugs...

DOI: 10.4414/smw.2005.11231 (opens in new tab) Ecstasy Emergency department Rhabdomyolysis Coma optics +2

Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.

Pharmacology, Biochemistry, and Behavior September 9, 2005 S. Moyano, J. Del Río, D. Frechilla 29 citations

Acute 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") treatment induces learning deficits in different animal models. In a passive avoidance learning task in rats, previous studies suggested a role for Ca2+/calmodulin-dependent protein kinase II (CaMKII) and N-methyl-D-aspartate (NMDA) receptors in the acute learning impairment. As cognitive deficits by "ecstasy" in humans have been only...

DOI: 10.1016/j.pbb.2005.07.020 (opens in new tab) Hippocampus Animals Rats, wistar N-methyl-3,4-methylenedioxyamphetamine +6

The P3 in ‘ecstasy’ polydrug users during response inhibition and execution

Journal of Psychopharmacology September 1, 2005 Alex Gamma, Daniel Brandeis, Ruven Brandeis et al. 36 citations

Substance abuse and associated externalizing disorders are characterized by behavioural disinhibition and low impulse control, with reduced neural inhibition postulated to be the common underlying brain mechanism. The P3 component of event-related potentials (ERPs) is a widely used neurophysiological measure thought to reflect inhibitory brain processes, but as yet has not been assessed in...

Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.

Neuropsychopharmacology August 2005 June M Young, Iain S. Mcgregor, Paul E Mallet

3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') and cannabis are two of the most commonly used illicit drugs in the western world, and are often used in combination. Very little research has examined their effect on cognitive function or behavior when combined, The present study used a double Y-maze task to examine the acute effect of MDMA and delta9-tetrahydrocannabinol (THC, the principal...

Neuropsychiatric Alterations in MDMA Users: Preliminary Findings

Annals of the New York Academy of Sciences August 1, 2005 Ronald I. Herning 17 citations

The use of marijuana is rampant among 3,4-methylenedioxymethamphetamine (MDMA) users. The co-occurrence of abuse of these two drugs has made it difficult to assess the specific residual effects of MDMA alone. As a first step toward identifying the effects of long-term MDMA use, we studied 8 MDMA abusers, 8 marijuana/MDMA abusers, 15 marijuana abusers (matched in marijuana use without MDMA use),...

DOI: 10.1196/annals.1344.003 (opens in new tab) MDMA Ecstasy Electroencephalography Hallucinogen +3

Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats

The International Journal of Neuropsychopharmacology August 1, 2005 Eszter Kirilly, Anita Benkő, Linda Ferrington et al. 26 citations

MDMA causes selective depletion of serotonergic terminals in experimental animals and the consequent decrease in synaptic 5-HT may, inter alia, increase impulsivity. To study the effects of MDMA upon brain function, the behaviour of male Dark Agouti rats exposed to MDMA (15 mg/kg i.p.), two 5-HT1B agonists (CGS-12066A and CP-94,253, both 5 mg/kg i.p.) or saline were investigated in the...

3,4-Methylenedioxymethamphetamine (MDMA) Intoxication in an Infant Chronically Exposed to Cocaine

Therapeutic Drug Monitoring July 22, 2005 Oscar García-algar, Nuria L Pez, M. Á. Bonet et al. 39 citations

Accidental ingestion of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) was detected in an infant admitted at the Pediatric Emergency Department by drug testing in urine. Concentrations of MDMA and its principal metabolite 4-hydroxy-3-methoxymethamphetamine (HMMA) in the infant's hydrolyzed urine were 11.7 mg/L and 34.4 mg/L, respectively. Apparent febrile convulsions and cardiovascular side...

Role of α2A‐adrenoceptors in the effects of MDMA on body temperature in the mouse

British Journal of Pharmacology July 18, 2005 Sotiria Bexis, James R. Docherty 43 citations

3,4‐Methylenedioxymetamphetamine (MDMA) produces complex effects on body temperature, including hypo‐ and hyperthermic components that vary with ambient temperature and strain of rat. We have previously reported that MDMA is an α 2 ‐adrenoceptor agonist, and α 2 ‐adrenoceptor agonists such as clonidine produce hypothermia. The purpose of this study was to investigate the effects of MDMA on core...

DOI: 10.1038/sj.bjp.0706320 (opens in new tab) MDMA Hypothermia Hyperthermia Clonidine +4

Mental disorders in current and former heavy ecstasy (MDMA) users

Addiction July 15, 2005 Rainer Thomasius, Kay Uwe Petersen, P. Zapletalova et al. 54 citations

ABSTRACT Background Ecstasy use has often been found to be associated with psychopathology, yet this research has so far been based largely on subjective symptom ratings. Aims To investigate whether ecstasy users suffered from long‐term psychopathological consequences. Measurements We compared the prevalence of Diagnostic and Statistical Manual version IV (DSM‐IV) mental disorders in 30 current...

Age-dependent (+)MDMA-mediated Neurotoxicity in Mice

Neurotoxicology July 6, 2005 María E. Reverón, Terrence J. Monks, Christine L. Duvauchelle 24 citations

In the present study the effects of a neurotoxic regimen of (+)-MDMA (20 mg/kgx4, s.c.) in 4- and 10-week-old C57Bl/6J mice during treatment and 7 days post-treatment were examined. Rectal temperatures monitored between (+)-MDMA injections (30 min post-injection/2 h intervals) revealed hyperthermic responses in both age groups, with the magnitude of the response significantly greater in older...